Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects

P. Vodicka, L. Musak, C. Frank, A. Kazimirova, V. Vymetalkova, M. Barancokova, B. Smolkova, Z. Dzupinkova, K. Jiraskova, S. Vodenkova, M. Kroupa, O. Osina, A. Naccarati, F. Palitti, A. Försti, M. Dusinska, L. Vodickova, K. Hemminki,

. 2015 ; 36 (11) : 1299-306. [pub] 20150908

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16009968

Human cancers are often associated with numerical and structural chromosomal instability. Structural chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBL) arise as consequences of direct DNA damage or due to replication on a damaged DNA template. In both cases, DNA repair is critical and inter-individual differences in its capacity are probably due to corresponding genetic variations. We investigated functional variants in DNA repair genes (base and nucleotide excision repair, double-strand break repair) in relation to CAs, chromatid-type aberrations (CTAs) and chromosome-type aberrations (CSAs) in healthy individuals. Chromosomal damage was determined by conventional cytogenetic analysis. The genotyping was performed by both restriction fragment length polymorphism and TaqMan allelic discrimination assays. Multivariate logistic regression was applied for testing individual factors on CAs, CTAs and CSAs. Pair-wise genotype interactions of 11 genes were constructed for all possible pairs of single-nucleotide polymorphisms. Analysed individually, we observed significantly lower CTA frequencies in association with XPD Lys751Gln homozygous variant genotype [odds ratio (OR) 0.64, 95% confidence interval (CI) 0.48-0.85, P = 0.004; n = 1777]. A significant association of heterozygous variant genotype in RAD54L with increased CSA frequency (OR 1.96, 95% CI 1.01-4.02, P = 0.03) was determined in 282 subjects with available genotype. By addressing gene-gene interactions, we discovered 14 interactions significantly modulating CAs, 9 CTAs and 12 CSAs frequencies. Highly significant interactions included always pairs from two different pathways. Although individual variants in genes encoding DNA repair proteins modulate CAs only modestly, several gene-gene interactions in DNA repair genes evinced either enhanced or decreased CA frequencies suggesting that CAs accumulation requires complex interplay between different DNA repair pathways.

Clinic of Occupational Medicine and Toxicology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava and University Hospital in Martin 03601 Martin Slovak Republic

Department of Agrobiology and Agrochemistry University of Tuscia 011000 Viterbo Italy

Department of Cancer Genetics Cancer Research Institute of Slovak Academy of Sciences 83391 Bratislava Slovak Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 14220 Prague Czech Republic Faculty of Medicine in Pilsen Charles University Prague 30605 Pilsen Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 14220 Prague Czech Republic Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague 12800 Prague Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 14220 Prague Czech Republic Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague 12800 Prague Czech Republic Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague 32300 Pilsen Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 14220 Prague Czech Republic Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague 12800 Prague Czech Republic Department of General Biology and Genetics 3rd Faculty of Medicine Charles University Prague 10000 Prague Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine Academy of Sciences of the Czech Republic 14220 Prague Czech Republic Molecular and Genetic Epidemiology Research Unit HuGeF Human Genetics Foundation 10126 Torino Italy

Division of Molecular Genetic Epidemiology German Cancer Research Centre 69120 Heidelberg Germany

Division of Molecular Genetic Epidemiology German Cancer Research Centre 69120 Heidelberg Germany Center for Primary Health Care Research Lund University 20506 Malmö Sweden and

Faculty of Medicine Slovak Medical University in Bratislava 83303 Bratislava Slovak Republic

Health Effects Laboratory MILK NILU Norwegian Institute for Air Research 2027 Kjeller Norway

Molecular Biology Service Research Institute for Molecular Pathology 1030 Vienna Austria

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16009968
003      
CZ-PrNML
005      
20160412124115.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/carcin/bgv127 $2 doi
024    7_
$a 10.1093/carcin/bgv127 $2 doi
035    __
$a (PubMed)26354780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 12800 Prague, Czech Republic, Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 32300 Pilsen, Czech Republic, pvodicka@biomed.cas.cz.
245    10
$a Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects / $c P. Vodicka, L. Musak, C. Frank, A. Kazimirova, V. Vymetalkova, M. Barancokova, B. Smolkova, Z. Dzupinkova, K. Jiraskova, S. Vodenkova, M. Kroupa, O. Osina, A. Naccarati, F. Palitti, A. Försti, M. Dusinska, L. Vodickova, K. Hemminki,
520    9_
$a Human cancers are often associated with numerical and structural chromosomal instability. Structural chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBL) arise as consequences of direct DNA damage or due to replication on a damaged DNA template. In both cases, DNA repair is critical and inter-individual differences in its capacity are probably due to corresponding genetic variations. We investigated functional variants in DNA repair genes (base and nucleotide excision repair, double-strand break repair) in relation to CAs, chromatid-type aberrations (CTAs) and chromosome-type aberrations (CSAs) in healthy individuals. Chromosomal damage was determined by conventional cytogenetic analysis. The genotyping was performed by both restriction fragment length polymorphism and TaqMan allelic discrimination assays. Multivariate logistic regression was applied for testing individual factors on CAs, CTAs and CSAs. Pair-wise genotype interactions of 11 genes were constructed for all possible pairs of single-nucleotide polymorphisms. Analysed individually, we observed significantly lower CTA frequencies in association with XPD Lys751Gln homozygous variant genotype [odds ratio (OR) 0.64, 95% confidence interval (CI) 0.48-0.85, P = 0.004; n = 1777]. A significant association of heterozygous variant genotype in RAD54L with increased CSA frequency (OR 1.96, 95% CI 1.01-4.02, P = 0.03) was determined in 282 subjects with available genotype. By addressing gene-gene interactions, we discovered 14 interactions significantly modulating CAs, 9 CTAs and 12 CSAs frequencies. Highly significant interactions included always pairs from two different pathways. Although individual variants in genes encoding DNA repair proteins modulate CAs only modestly, several gene-gene interactions in DNA repair genes evinced either enhanced or decreased CA frequencies suggesting that CAs accumulation requires complex interplay between different DNA repair pathways.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a chromozomální aberace $7 D002869
650    _2
$a DNA-glykosylasy $x genetika $7 D045647
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory $x genetika $7 D009369
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Musak, Ludovit $u Clinic of Occupational Medicine and Toxicology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital in Martin, 03601 Martin, Slovak Republic.
700    1_
$a Frank, Christoph $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
700    1_
$a Kazimirova, Alena $u Faculty of Medicine, Slovak Medical University in Bratislava, 83303 Bratislava, Slovak Republic.
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 12800 Prague, Czech Republic.
700    1_
$a Barancokova, Magdalena $u Faculty of Medicine, Slovak Medical University in Bratislava, 83303 Bratislava, Slovak Republic.
700    1_
$a Smolkova, Bozena $u Department of Cancer Genetics, Cancer Research Institute of Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic.
700    1_
$a Dzupinkova, Zuzana $u Molecular Biology Service, Research Institute for Molecular Pathology, 1030 Vienna, Austria.
700    1_
$a Jiraskova, Katerina $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 12800 Prague, Czech Republic.
700    1_
$a Vodenkova, Sona $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 12800 Prague, Czech Republic, Department of General Biology and Genetics, 3rd Faculty of Medicine, Charles University in Prague, 10000 Prague, Czech Republic.
700    1_
$a Kroupa, Michal $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Faculty of Medicine in Pilsen, Charles University in Prague, 30605 Pilsen, Czech Republic.
700    1_
$a Osina, Oto $u Clinic of Occupational Medicine and Toxicology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital in Martin, 03601 Martin, Slovak Republic.
700    1_
$a Naccarati, Alessio $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Molecular and Genetic Epidemiology Research Unit, HuGeF-Human Genetics Foundation, 10126 Torino, Italy.
700    1_
$a Palitti, Fabrizio $u Department of Agrobiology and Agrochemistry, University of Tuscia, 011000 Viterbo, Italy.
700    1_
$a Försti, Asta $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany, Center for Primary Health Care Research, Lund University, 20506 Malmö, Sweden and.
700    1_
$a Dusinska, Maria $u Health Effects Laboratory MILK, NILU-Norwegian Institute for Air Research, 2027 Kjeller, Norway.
700    1_
$a Vodickova, Ludmila $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic, Institute of Biology and Medical Genetics, 1st Faculty of Medicine, Charles University in Prague, 12800 Prague, Czech Republic, Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 32300 Pilsen, Czech Republic.
700    1_
$a Hemminki, Kari $u Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany, Center for Primary Health Care Research, Lund University, 20506 Malmö, Sweden and.
773    0_
$w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 36, č. 11 (2015), s. 1299-306
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26354780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160412124158 $b ABA008
999    __
$a ok $b bmc $g 1113397 $s 934336
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 36 $c 11 $d 1299-306 $e 20150908 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...